Efficacy and safety of low‐dose antihypertensive combination of amlodipine, telmisartan, and chlorthalidone: A randomized, double‐blind, parallel, phase II trial

The aim of this clinical trial was to assess the efficacy and safety of low‐dose triple combinations of amlodipine, telmisartan, and chlorthalidone in patients with essential hypertension. After a 2‐week placebo run‐in period, 176 patients were randomized to seven treatment groups (placebo, quarter‐...

Descripción completa

Detalles Bibliográficos
Autores principales: Sung, Ki‐Chul, Sung, Jung Hoon, Cho, Eun Joo, Ahn, Jeong Cheon, Han, Seung Hwan, Kim, Weon, Kim, Kye Hun, Sohn, Il Suk, Shin, Jinho, Kim, Seok Yeon, Kim, Kwang‐il, Kang, Seok Min, Park, Sung‐Ji, Kim, Yong‐Jin, Shin, Joon‐Han, Park, Seong‐Mi, Park, Chang‐Gyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Treatment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581102/
https://www.ncbi.nlm.nih.gov/pubmed/36094783
http://dx.doi.org/10.1111/jch.14570

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581102/
https://www.ncbi.nlm.nih.gov/pubmed/36094783
http://dx.doi.org/10.1111/jch.14570

Ejemplares similares